Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001130319-06-000220
Filing Date
2006-03-27
Accepted
2006-03-27 10:59:54
Documents
2
Period of Report
2006-03-27

Document Format Files

Seq Description Document Type Size
1 FORM 6-K: PRESS RELEASE DATED MARCH 27TH, 2006 o30790e6vk.htm 6-K 14936
2 GRAPHIC o30790o3079000.gif GRAPHIC 3943
  Complete submission text file 0001130319-06-000220.txt   21944
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 06710957
SIC: 2834 Pharmaceutical Preparations